-
Clivatuzumab
2025-09-05
-
BI-1622
2025-09-05
-
Panobacumab
2025-09-04
-
HSP90-IN-27
2025-09-04
-
Vesnarinone
2025-09-03
-
Aβ42-IN-2
2025-09-03
-
GDC-0349
2025-09-02
-
Recombinant Human IL-12
2025-09-02
-
8-OH-DPAT
2025-08-30
-
Ac-DNLD-AMC
2025-08-29
-
ICI 199,441 hydrochloride
2025-08-28
-
Oosporein
2025-08-28
-
BAY 61-3606
2025-08-27
-
(-)-Quinpirole hydrochloride
2025-08-27
-
Cyclapolin 9
2025-08-26